Latest California Healthline Stories
Watch: Big Week For Drug Pricing Debate Featured On C-SPAN
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program “Washington Journal,” where she fielded viewers’ calls about high drug prices and industry criticism.
Readers And Tweeters Give Free Consultation On Health Care System’s Ills
Kaiser Health News and California Healthline give readers a chance to comment on a recent batch of stories.
Americans Ready To Crack Down On Drug Prices That Force Some To Skip Doses
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
¡Miau-ch! Le cobran $48,152 por una droga contra la rabia
Una bióloga de Florida, amante de los animales, quiso alimentar a un gato callejero. Lo que siguió fue una pesadilla de gastos médicos inesperados.
An animal lover stopped to feed a hungry-looking stray cat outside Everglades National Park in Florida. First, the cat bit her finger — then the hospital billed her close to $50,000 for a treatment that typically costs about $3,000.
Cancer’s Complications: Confusing Bills, Maddening Errors And Endless Phone Calls
Carol Marley has pancreatic cancer — and dealing with its financial toll has become her full-time job.
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesday’s Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
Progressives Tout ‘Medicare-For-All’ But States Eye ‘Medicaid Buy-In’
New Mexico is one of several states looking at offering consumers a government-sponsored plan. The proposals would typically have benefits similar to what is available in Medicaid, the state-federal health plan for low-income people.
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.